CARR EDWARD
CHIEF ACCOUNTING OFFICER
CARR EDWARD has filed 2 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, CARR EDWARD is listed as CHIEF ACCOUNTING OFFICER at Dianthus Therapeutics, Inc. Inside the rolling window, CARR EDWARD reported no open-market purchases and 2 open-market sales totaling $5.6M in DNTH. The largest disclosed transaction in the window is a sale of 43,682 DNTH shares on Mar 12, 2026, worth $3.6M.
Companies traded
Other insiders at DNTH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has CARR EDWARD made?
CARR EDWARD has filed 2 SEC Form 4 filings (14 transaction rows) across 1 company since 2026.
Which companies does CARR EDWARD trade?
CARR EDWARD has filed SEC Form 4 disclosures for 1 company, including DNTH.
When was CARR EDWARD's most recent SEC Form 4 filing?
CARR EDWARD's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is CARR EDWARD's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, CARR EDWARD is listed as CHIEF ACCOUNTING OFFICER.
What is CARR EDWARD's total buy and sell value in the current window?
Inside the rolling retention window, CARR EDWARD bought $0 and sold $5.6M based on SEC Form 4 filings.
What was CARR EDWARD's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 43,682 DNTH shares on 2026-03-12, worth $3.6M, per SEC Form 4 filings.